Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner

Particle and Fibre Toxicology

Volumn 7, Issue , 2010, Pages

  Rondini, Elizabeth A ^a   Walters, Dianne M ^b   Bauer, Alison K ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CHEMOKINE; CORN OIL; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; FUEL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATE BUFFERED SALINE; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; VANADIUM PENTOXIDE; CARCINOGEN; VANADIUM DERIVATIVE;

A J MOUSE; AIR POLLUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CANCER RISK; COMBUSTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; ENZYME ACTIVATION; GENETIC SUSCEPTIBILITY; INBRED STRAIN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG HOMOGENATE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARTICULATE MATTER; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; TUMOR GROWTH; AIR POLLUTANT; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; EXPOSURE; GENETIC PREDISPOSITION; GENETICS; LUNG INJURY; LUNG TUMOR; METABOLISM; SPECIES DIFFERENCE;

ANIMALIA; MUS; ZEA MAYS;

AIR POLLUTANTS; ANIMALS; CARCINOGENS; CHEMOKINES; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; INHALATION EXPOSURE; LUNG INJURY; LUNG NEOPLASMS; METHYLCHOLANTHRENE; MICE; MICE, INBRED A; MICE, INBRED BALB C; MICE, INBRED C57BL; SPECIES SPECIFICITY; TRANSCRIPTION FACTORS; VANADIUM COMPOUNDS;

EID: 77950686401     PISSN: 17438977     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-8977-7-9     Document Type: Article

References (85)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality, and prevalence worldwide 2004, Lyon, France: IARC Press.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66. 10.3322/canjclin.57.1.43, 17237035.
3. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006, 98:691-699.
4. Siemiatycki J, Richardson L, Straif K, Latreille B, Lakhani R, Campbell S, Rousseau MC, Boffetta P. Listing occupational carcinogens. Environ Health Perspect 2004, 112:1447-1459. 1247606, 15531427.
5. Barbone F, Bovenzi M, Cavallieri F, Stanta G. Air-Pollution and Lung-Cancer in Trieste, Italy. American Journal of Epidemiology 1995, 141:1161-1169.
6. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993, 329:1753-1759. 10.1056/NEJM199312093292401, 8179653.
7. Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. Jama 2002, 287:1132-1141. 10.1001/jama.287.9.1132, 11879110.
8. Pope CA, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995, 151:669-674.
9. U.S.EPA Air Quality Criteria for Particulate Matter (Final Report, Oct 2004) 2004, Washington, DC, USA: U.S. Environmental Protection Agency, U.S.EPA.
10. WHO Health Aspects of Air Pollution with Particulate Matter, Ozone and Nitrogen Dioxide 2003, Bonn, Germany: World Health Organization (WHO), WHO.
11. Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles. Br J Ind Med 1980, 37:337-362. 1008751, 7004477.
12. Cohen AJ, Ross Anderson H, Ostro B, Pandey KD, Krzyzanowski M, Kunzli N, Gutschmidt K, Pope A, Romieu I, Samet JM, Smith K. The global burden of disease due to outdoor air pollution. J Toxicol Environ Health A 2005, 68:1301-1307. 10.1080/15287390590936166, 16024504.
13. Galaris D, Evangelou A. The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit Rev Oncol Hematol 2002, 42:93-103. 10.1016/S1040-8428(01)00212-8, 11923071.
14. Knaapen AM, Borm PJ, Albrecht C, Schins RP. Inhaled particles and lung cancer. Part A: Mechanisms. Int J Cancer 2004, 109:799-809. 10.1002/ijc.11708, 15027112.
15. Bonner JC. Lung fibrotic responses to particle exposure. Toxicol Pathol 2007, 35:148-153. 10.1080/01926230601060009, 17325983.
16. Costa DL, Dreher KL. Bioavailable transition metals in particulate matter mediate cardiopulmonary injury in healthy and compromised animal models. Environ Health Perspect 1997, 105(Suppl 5):1053-1060. 10.2307/3433509, 1470172, 9400700.
17. Dreher KL, Jaskot RH, Lehmann JR, Richards JH, McGee JK, Ghio AJ, Costa DL. Soluble transition metals mediate residual oil fly ash induced acute lung injury. J Toxicol Environ Health 1997, 50:285-305. 10.1080/009841097160492, 9055877.
18. Kadiiska MB, Mason RP, Dreher KL, Costa DL, Ghio AJ. In vivo evidence of free radical formation in the rat lung after exposure to an emission source air pollution particle. Chemical Research in Toxicology 1997, 10:1104-1108. 10.1021/tx970049r, 9348432.
19. Saldiva PH, Clarke RW, Coull BA, Stearns RC, Lawrence J, Murthy GG, Diaz E, Koutrakis P, Suh H, Tsuda A, Godleski JJ. Lung inflammation induced by concentrated ambient air particles is related to particle composition. Am J Respir Crit Care Med 2002, 165:1610-1617. 10.1164/rccm.2106102, 12070061.
20. IARC Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide 2006, Lyon, France: International Agency for Research on Cancer (IARC), IARC.
21. Sadiq M, Mian AA. Nickel and Vanadium in Air Particulates at Dhahran (Saudi-Arabia) During and after the Kuwait Oil Fires. Atmospheric Environment 1994, 28:2249-2253.
22. Hauser R, Eisen EA, Pothier L, Christiani DC. A prospective study of lung function among boilermaker construction workers exposed to combustion particulates. Am J Ind Med 2001, 39:454-462. 10.1002/ajim.1039, 11333407.
23. Hauser R, Eisen EA, Pothier L, Lewis D, Bledsoe T, Christiani DC. Spirometric abnormalities associated with chronic bronchitis, asthma, and airway hyperresponsiveness among boilermaker construction workers. Chest 2002, 121:2052-2060. 10.1378/chest.121.6.2052, 12065377.
24. Irsigler GB, Visser PJ, Spangenberg PA. Asthma and chemical bronchitis in vanadium plant workers. Am J Ind Med 1999, 35:366-374. 10.1002/(SICI)1097-0274(199904)35:4<366::AID-AJIM7>3.0.CO;2-N, 10086213.
25. Hauser R, Elreedy S, Hoppin JA, Christiani DC. Upper airway response in workers exposed to fuel oil ash: nasal lavage analysis. Occup Environ Med 1995, 52:353-358. 10.1136/oem.52.5.353, 1128229, 7795759.
26. Knecht EA, Moorman WJ, Clark JC, Lynch DW, Lewis TR. Pulmonary effects of acute vanadium pentoxide inhalation in monkeys. Am Rev Respir Dis 1985, 132:1181-1185.
27. Bonner JC, Rice AB, Ingram JL, Moomaw CR, Nyska A, Bradbury A, Sessoms AR, Chulada PC, Morgan DL, Zeldin DC, Langenbach R. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 2002, 161:459-470. 1850724, 12163371.
28. Bonner JC, Rice AB, Moomaw CR, Morgan DL. Airway fibrosis in rats induced by vanadium pentoxide. Am J Physiol Lung Cell Mol Physiol 2000, 278:L209-216.
29. Pierce LM, Alessandrini F, Godleski JJ, Paulauskis JD. Vanadium-induced chemokine mRNA expression and pulmonary inflammation. Toxicol Appl Pharmacol 1996, 138:1-11. 10.1006/taap.1996.9999, 8658498.
30. Ress NB, Chou BJ, Renne RA, Dill JA, Miller RA, Roycroft JH, Hailey JR, Haseman JK, Bucher JR. Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol Sci 2003, 74:287-296. 10.1093/toxsci/kfg136, 12773761.
31. Ehrlich VA, Nersesyan AK, Hoelzi C, Ferk F, Bichler J, Valic E, Schaffer A, Schulte-Hermann R, Fenech M, Wagner KH, Knasmuller S. Inhalative Exposure to Vanadium Pentoxide Causes DNA Damage in Workers: Results of a Multiple End Point Study. Environmental Health Perspectives 2008, 116:1689-1693. 10.1289/ehp.11438, 2599764, 19079721.
32. Sorensen M, Schins RP, Hertel O, Loft S. Transition metals in personal samples of PM2.5 and oxidative stress in human volunteers. Cancer Epidemiol Biomarkers Prev 2005, 14:1340-1343. 10.1158/1055-9965.EPI-04-0899, 15894700.
33. Hickey RJ, Schoff EP, Clelland RC. Relationship between air pollution and certain chronic disease death rates. Multivariate statistical studies. Arch Environ Health 1967, 15:728-738.
34. Boice JD, Mumma MT, Blot WJ. Cancer and noncancer mortality in populations living near uranium and vanadium mining and milling operations in Montrose County, Colorado, 1950-2000. Radiation Research 2007, 167:711-726. 10.1667/RR0839.1, 17523851.
35. Rivedal E, Roseng LE, Sanner T. Vanadium compounds promote the induction of morphological transformation of hamster embryo cells with no effect on gap junctional cell communication. Cell Biol Toxicol 1990, 6:303-314. 10.1007/BF02443805, 2253055.
36. Bauer AK, Malkinson AM, Kleeberger SR. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities. Am J Physiol Lung Cell Mol Physiol 2004, 287:L685-703. 10.1152/ajplung.00223.2003, 15355860.
37. Bauer AK, Dwyer-Nield LD, Keil K, Koski K, Malkinson AM. Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion. Exp Lung Res 2001, 27:197-216. 10.1080/019021401300053948, 11293324.
38. Malkinson AM, Radcliffe RA, Bauer AK. Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice. Carcinogenesis 2002, 23:411-417. 10.1093/carcin/23.3.411, 11895855.
39. Miller YE, Dwyer-Nield LD, Keith RL, Le M, Franklin WA, Malkinson AM. Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections. Cancer Lett 2003, 198:139-144. 10.1016/S0304-3835(03)00309-4, 12957351.
40. Ewart SL, Kuperman D, Schadt E, Tankersley C, Grupe A, Shubitowski DM, Peltz G, Wills-Karp M. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol 2000, 23:537-545.
41. Lewkowich IP, Lajoie S, Clark JR, Herman NS, Sproles AA, Wills-Karp M. Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS One 2008, 3:e3879. 10.1371/journal.pone.0003879, 2586658, 19060952.
42. Bauer AK, Dwyer-Nield LD, Hankin JA, Murphy RC, Malkinson AM. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice. Toxicology 2001, 169:1-15. 10.1016/S0300-483X(01)00475-9, 11696405.
43. Foster WM, Walters DM, Longphre M, Macri K, Miller LM. Methodology for the measurement of mucociliary function in the mouse by scintigraphy. J Appl Physiol 2001, 90:1111-1117.
44. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, Kleeberger SR. Role of NRF2 in protection against hyperoxic lung injury in mice. Am J Respir Cell Mol Biol 2002, 26:175-182.
45. Ainbinder E, Bergelson S, Pinkus R, Daniel V. Regulatory mechanisms involved in activator-protein-1 (AP-1)-mediated activation of glutathione-S-transferase gene expression by chemical agents. Eur J Biochem 1997, 243:49-57. 10.1111/j.1432-1033.1997.0049a.x, 9030721.
46. Bergelson S, Pinkus R, Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res 1994, 54:36-40.
47. Kwon YW, Ueda S, Ueno M, Yodoi J, Masutani H. Mechanism of p53-dependent apoptosis induced by 3-methylcholanthrene: involvement of p53 phosphorylation and p38 MAPK. J Biol Chem 2002, 277:1837-1844. 10.1074/jbc.M105033200, 11706017.
48. Bauer AK, Dixon D, DeGraff LM, Cho HY, Walker CR, Malkinson AM, Kleeberger SR. Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis. J Natl Cancer Inst 2005, 97:1778-1781.
49. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
50. Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 2008, 8:605-615. 10.1586/14737140.8.4.605, 18402527.
51. Bauer AK, Rondini EA. Review paper: the role of inflammation in mouse pulmonary neoplasia. Vet Pathol 2009, 46:369-390. 10.1354/vp.08-VP-0217-B-REV, 19176494.
52. Ji H, Houghton AM, Mariani TJ, Perera S, Kim CB, Padera R, Tonon G, McNamara K, Marconcini LA, Hezel A, et al. K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006, 25:2105-2112. 10.1038/sj.onc.1209237, 16288213.
53. Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, Tang H, Burdick MD, Sato M, Minna JD, et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 2006, 66:4198-4207. 10.1158/0008-5472.CAN-05-3842, 16618742.
54. Festing MF, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM, You M. At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J × BALB/c mice. Genomics 1998, 53:129-136. 10.1006/geno.1998.5450, 9790761.
55. Obata M, Nishimori H, Ogawa K, Lee GH. Identification of the Par2 (Pulmonary adenoma resistance) locus on mouse chromosome 18, a major genetic determinant for lung carcinogen resistance in BALB/cByJ mice. Oncogene 1996, 13:1599-1604.
56. Wang L, Medan D, Mercer R, Overmiller D, Leornard S, Castranova V, Shi X, Ding M, Huang C, Rojanasakul Y. Vanadium-induced apoptosis and pulmonary inflammation in mice: Role of reactive oxygen species. J Cell Physiol 2003, 195:99-107. 10.1002/jcp.10232, 12599213.
57. Wang YZ, Ingram JL, Walters DM, Rice AB, Santos JH, Van Houten B, Bonner JC. Vanadium-induced STAT-1 activation in lung myofibroblasts requires H2O2 and P38 MAP kinase. Free Radic Biol Med 2003, 35:845-855. 10.1016/S0891-5849(03)00399-X, 14556849.
58. Grabowski GM, Paulauskis JD, Godleski JJ. Mediating phosphorylation events in the vanadium-induced respiratory burst of alveolar macrophages. Toxicol Appl Pharmacol 1999, 156:170-178. 10.1006/taap.1999.8642, 10222309.
59. Huang C, Chen N, Ma WY, Dong Z. Vanadium induces AP-1- and NFkappB-dependent transcription activity. Int J Oncol 1998, 13:711-715.
60. Ingram JL, Rice AB, Santos J, Van Houten B, Bonner JC. Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases. Am J Physiol Lung Cell Mol Physiol 2003, 284:L774-782.
61. Wang YZ, Bonner JC. Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts. Am J Respir Cell Mol Biol 2000, 22:590-596.
62. Samet JM, Graves LM, Quay J, Dailey LA, Devlin RB, Ghio AJ, Wu W, Bromberg PA, Reed W. Activation of MAPKs in human bronchial epithelial cells exposed to metals. Am J Physiol 1998, 275:L551-558.
63. Chen F, Demers LM, Vallyathan V, Ding M, Lu Y, Castranova V, Shi X. Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages. J Biol Chem 1999, 274:20307-20312. 10.1074/jbc.274.29.20307, 10400652.
64. Ding M, Li JJ, Leonard SS, Ye JP, Shi X, Colburn NH, Castranova V, Vallyathan V. Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis 1999, 20:663-668. 10.1093/carcin/20.4.663, 10223197.
65. Antao-Menezes A, Turpin EA, Bost PC, Ryman-Rasmussen JP, Bonner JC. STAT-1 signaling in human lung fibroblasts is induced by vanadium pentoxide through an IFN-beta autocrine loop. J Immunol 2008, 180:4200-4207.
66. Samet JM, Silbajoris R, Wu W, Graves LM. Tyrosine phosphatases as targets in metal-induced signaling in human airway epithelial cells. Am J Respir Cell Mol Biol 1999, 21:357-364.
67. Carter JD, Ghio AJ, Samet JM, Devlin RB. Cytokine production by human airway epithelial cells after exposure to an air pollution particle is metal-dependent. Toxicol Appl Pharmacol 1997, 146:180-188. 10.1006/taap.1997.8254, 9344885.
68. Chong IW, Shi MM, Love JA, Christiani DC, Paulauskis JD. Regulation of chemokine mRNA expression in a rat model of vanadium-induced pulmonary inflammation. Inflammation 2000, 24:505-517. 10.1023/A:1007021322323, 11128049.
69. Huang S, Paulauskis JD, Kobzik L. Rat KC cDNA cloning and mRNA expression in lung macrophages and fibroblasts. Biochem Biophys Res Commun 1992, 184:922-929. 10.1016/0006-291X(92)90679-F, 1374243.
70. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989, 169:1485-1490. 10.1084/jem.169.4.1485, 2189236, 2926331.
71. Gungor N, Pennings JL, Knaapen AM, Chiu RK, Peluso M, Godschalk RW, van Schooten FJ. Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils. Respir Res 2010, 11:24. 10.1186/1465-9921-11-24, 2838834, 20184723.
72. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006, 6:24-37. 10.1038/nrc1782, 16397525.
73. Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 2004, 91:1970-1976. 10.1038/sj.bjc.6602227, 2409768, 15545974.
74. Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 2007, 56:25-33. 10.1016/j.lungcan.2006.11.014, 17175059.
75. de Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 2000, 190:619-626. 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO;2-6, 10727989.
76. Tomaki M, Sugiura H, Koarai A, Komaki Y, Akita T, Matsumoto T, Nakanishi A, Ogawa H, Hattori T, Ichinose M. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulm Pharmacol Ther 2007, 20:596-605. 10.1016/j.pupt.2006.06.006, 16919984.
77. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, Burdick MD, Iannettoni MD, Strieter RM. Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother 2000, 49:63-70. 10.1007/s002620050603, 10823415.
78. Chapman RW, Minnicozzi M, Celly CS, Phillips JE, Kung TT, Hipkin RW, Fan X, Rindgen D, Deno G, Bond R, et al. A novel, orally active CXCR1/2 receptor antagonist, Sch52 inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther 2007, 322:486-493. 10.1124/jpet.106.119040, 17496165.
79. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 2004, 172:2853-2860.
80. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004, 6:447-458. 10.1016/j.ccr.2004.09.028, 15542429.
81. Ji H, Wang Z, Perera SA, Li D, Liang MC, Zaghlul S, McNamara K, Chen L, Albert M, Sun Y, et al. Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models. Cancer Res 2007, 67:4933-4939. 10.1158/0008-5472.CAN-06-4592, 17510423.
82. Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26:3291-3310. 10.1038/sj.onc.1210422, 17496923.
83. Stathopoulos GT, Sherrill TP, Cheng DS, Scoggins RM, Han W, Polosukhin VV, Connelly L, Yull FE, Fingleton B, Blackwell TS. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci USA 2007, 104:18514-18519. 10.1073/pnas.0705316104, 2141808, 18000061.
84. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072:129-157.
85. Devereux TR, Holliday W, Anna C, Ress N, Roycroft J, Sills RC. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 2002, 23:1737-1743. 10.1093/carcin/23.10.1737, 12376484.